Antirheumatic agents in covid-19: is IL-6 the right target? | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Correspondence

Antirheumatic agents in covid-19: is IL-6 the right target?

Online download statistics by month:

Online download statistics by month: April 2020 to March 2024

	Abstract	Full	Pdf
Apr 2020	3023	2990	718
May 2020	566	553	193
Jun 2020	396	391	78
Jul 2020	162	152	41
Aug 2020	87	86	31
Sep 2020	100	72	30
Oct 2020	55	53	29
Nov 2020	42	38	13
Dec 2020	232	224	54
Jan 2021	133	128	49
Feb 2021	76	67	36
Mar 2021	122	109	36
Apr 2021	91	78	41
May 2021	71	53	35
Jun 2021	78	66	42
Jul 2021	66	51	13
Aug 2021	70	63	35
Sep 2021	84	76	32
Oct 2021	126	113	30
Nov 2021	78	56	33
Dec 2021	65	50	20
Jan 2022	67	60	18
Feb 2022	35	33	18
Mar 2022	38	38	23
Apr 2022	47	45	10
May 2022	42	39	9
Jun 2022	43	41	19
Jul 2022	50	52	10
Aug 2022	44	42	10
Sep 2022	47	41	18
Oct 2022	45	44	12
Nov 2022	20	19	8
Dec 2022	16	14	6
Jan 2023	33	31	25
Feb 2023	32	32	1
Mar 2023	39	38	12
Apr 2023	14	1	1
May 2023	51	3	5
Jun 2023	14	0	0
Jul 2023	31	0	2
Aug 2023	29	1	1
Sep 2023	26	0	1
Oct 2023	36	4	4
Nov 2023	26	1	2
Dec 2023	31	3	7
Jan 2024	19	0	3
Feb 2024	18	1	9
Mar 2024	35	1	3
Total	6651	6053	1826